Fortress Biotech (FBIO) Competitors $1.91 +0.08 (+4.32%) As of 07/3/2025 03:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBIO vs. CDXS, AGEN, SGMO, IRWD, DOMH, ACHV, CRIS, SABS, BOLT, and MTEMShould you be buying Fortress Biotech stock or one of its competitors? The main competitors of Fortress Biotech include Codexis (CDXS), Agenus (AGEN), Sangamo Therapeutics (SGMO), Ironwood Pharmaceuticals (IRWD), Dominari (DOMH), Achieve Life Sciences (ACHV), Curis (CRIS), SAB Biotherapeutics (SABS), Bolt Biotherapeutics (BOLT), and Molecular Templates (MTEM). These companies are all part of the "biotechnology" industry. Fortress Biotech vs. Its Competitors Codexis Agenus Sangamo Therapeutics Ironwood Pharmaceuticals Dominari Achieve Life Sciences Curis SAB Biotherapeutics Bolt Biotherapeutics Molecular Templates Codexis (NASDAQ:CDXS) and Fortress Biotech (NASDAQ:FBIO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability. Do analysts prefer CDXS or FBIO? Codexis currently has a consensus price target of $11.00, suggesting a potential upside of 298.55%. Fortress Biotech has a consensus price target of $21.00, suggesting a potential upside of 1,000.05%. Given Fortress Biotech's stronger consensus rating and higher possible upside, analysts plainly believe Fortress Biotech is more favorable than Codexis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Codexis 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, CDXS or FBIO? Codexis has a beta of 2.52, indicating that its stock price is 152% more volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Do insiders & institutionals hold more shares of CDXS or FBIO? 78.5% of Codexis shares are held by institutional investors. Comparatively, 96.5% of Fortress Biotech shares are held by institutional investors. 2.1% of Codexis shares are held by company insiders. Comparatively, 27.9% of Fortress Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher earnings and valuation, CDXS or FBIO? Fortress Biotech has lower revenue, but higher earnings than Codexis. Codexis is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCodexis$59.35M3.85-$65.28M-$0.99-2.79Fortress Biotech$57.67M0.98-$46M-$2.23-0.86 Is CDXS or FBIO more profitable? Fortress Biotech has a net margin of -71.24% compared to Codexis' net margin of -149.47%. Codexis' return on equity of -118.47% beat Fortress Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Codexis-149.47% -118.47% -53.37% Fortress Biotech -71.24%-4,712.53%-27.67% Does the media refer more to CDXS or FBIO? In the previous week, Codexis' average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score. Company Overall Sentiment Codexis Neutral Fortress Biotech Neutral SummaryFortress Biotech beats Codexis on 9 of the 14 factors compared between the two stocks. Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBIO vs. The Competition Export to ExcelMetricFortress BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$55.59M$2.91B$5.53B$9.05BDividend YieldN/A2.44%5.24%4.03%P/E Ratio-0.8621.5627.5220.22Price / Sales0.98281.76421.02118.64Price / CashN/A42.7336.8958.07Price / Book-31.827.518.045.67Net Income-$46M-$55.05M$3.18B$249.13M7 Day Performance4.89%4.61%2.90%3.28%1 Month Performance1.54%4.72%3.70%5.55%1 Year Performance6.06%5.92%36.15%21.12% Fortress Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBIOFortress Biotech2.1667 of 5 stars$1.91+4.3%$21.00+1,000.1%+8.5%$55.59M$57.67M-0.86170Gap UpCDXSCodexis2.9586 of 5 stars$2.44+2.1%$11.00+350.8%-4.2%$198M$59.35M-2.46250Positive NewsAGENAgenus4.2771 of 5 stars$4.57-4.0%$14.00+206.3%-59.2%$130.50M$103.46M-0.53440SGMOSangamo Therapeutics2.7173 of 5 stars$0.54+0.1%$4.50+731.3%+66.5%$126.12M$57.80M-1.39480IRWDIronwood Pharmaceuticals4.6396 of 5 stars$0.72-1.9%$4.78+566.9%-87.9%$118.27M$351.41M-3.59220DOMHDominari0.3708 of 5 stars$5.44-2.0%N/A+162.2%$81.27M$18.15M0.004Gap UpACHVAchieve Life Sciences1.627 of 5 stars$2.26+1.3%$14.33+534.2%-51.2%$77.35MN/A-1.6920Gap UpHigh Trading VolumeCRISCuris2.8968 of 5 stars$2.32+6.9%$17.00+632.8%-70.6%$22.70M$10.91M-0.3760News CoverageHigh Trading VolumeSABSSAB Biotherapeutics3.0761 of 5 stars$1.76+3.8%$13.25+655.0%-41.0%$15.70M$1.32M0.00140News CoveragePositive NewsGap UpBOLTBolt Biotherapeutics3.0109 of 5 stars$5.77+2.9%$50.00+766.6%-58.7%$10.75M$7.69M-0.1790News CoveragePositive NewsHigh Trading VolumeMTEMMolecular TemplatesN/AN/AN/AN/A$1K$23.48M0.00260 Related Companies and Tools Related Companies CDXS Alternatives AGEN Alternatives SGMO Alternatives IRWD Alternatives DOMH Alternatives ACHV Alternatives CRIS Alternatives SABS Alternatives BOLT Alternatives MTEM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBIO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
